ICD-10 Chapter XXII

Metadata

Coding system
ICD-10
Coding system release
combined_20260909105914_47430d19
Organisation
OpenSAFELY
Codelist ID
opensafely/icd-10-chapter-xxii
Version ID
5cada600
Number of codes included
133

Actions

Versions

About

Methodology

This codelist is for the whole of Chapter XXII. A925, U06 and U069 are all Zika - but only U06 and U069 are in Chapter I so A925 is deliberately omitted and the warning can be ignored. A925 appears in the codelist for Chapter I


Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.

We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.

code term
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use
U04 Severe acute respiratory syndrome [SARS]
U049 Severe acute respiratory syndrome [SARS], unspecified
U06 Zika virus disease
U060 Emergency use of U06.0
U061 Emergency use of U06.1
U062 Emergency use of U06.2
U063 Emergency use of U06.3
U064 Emergency use of U06.4
U065 Emergency use of U06.5
U066 Emergency use of U06.6
U067 Emergency use of U06.7
U068 Emergency use of U06.8
U069 Zika virus disease
U07 Emergency use of U07
U070 Vaping-related disorder
U071 COVID-19, virus identified
U072 COVID-19, virus not identified
U073 Personal history of COVID-19
U074 Post COVID-19 condition
U075 Multisystem inflammatory syndrome associated with COVID-19
U076 Need for immunization against COVID-19
U077 COVID-19 vaccines causing adverse effects in therapeutic use
U078 Emergency use of U07.8
U079 Emergency use of U07.9
U08 Personal history of COVID-19
U089 Personal history of COVID-19, unspecified
U09 Post COVID-19 condition
U099 Post COVID-19 condition, unspecified
U10 Multisystem inflammatory syndrome associated with COVID-19
U109 Multisystem inflammatory syndrome associated with COVID-19, unspecified
U11 Need for immunization against COVID-19
U119 Need for immunization against COVID-19, unspecified
U12 COVID-19 vaccines causing adverse effects in therapeutic use
U129 COVID-19 vaccines causing adverse effects in therapeutic use, unspecified
U13 Emergency use of U13
U139 Emergency use of U13.9
U14 Emergency use of U14
U149 Emergency use of U14.9
U15 Emergency use of U15
U159 Emergency use of U15.9
U16 Emergency use of U16
U169 Emergency use of U16.9
U17 Emergency use of U17
U179 Emergency use of U17.9
U18 Emergency use of U18
U189 Emergency use of U18.9
U19 Emergency use of U19
U199 Emergency use of U19.9
U20 Emergency use of U20
U209 Emergency use of U20.9
U21 Emergency use of U21
U219 Emergency use of U21.9
U22 Emergency use of U22
U229 Emergency use of U22.9
U23 Emergency use of U23
U239 Emergency use of U23.9
U24 Emergency use of U24
U249 Emergency use of U24.9
U25 Emergency use of U25
U259 Emergency use of U25.9
U26 Emergency use of U26
U269 Emergency use of U26.9
U27 Emergency use of U27
U279 Emergency use of U27.9
U28 Emergency use of U28
U289 Emergency use of U28.9
U29 Emergency use of U29
U299 Emergency use of U29.9
U30 Emergency use of U30
U309 Emergency use of U30.9
U31 Emergency use of U31
U319 Emergency use of U31.9
U32 Emergency use of U32
U329 Emergency use of U32.9
U33 Emergency use of U33
U339 Emergency use of U33.9
U34 Emergency use of U34
U349 Emergency use of U34.9
U35 Emergency use of U35
U359 Emergency use of U35.9
U36 Emergency use of U36
U369 Emergency use of U36.9
U37 Emergency use of U37
U379 Emergency use of U37.9
U38 Emergency use of U38
U389 Emergency use of U38.9
U39 Emergency use of U39
U399 Emergency use of U39.9
U40 Emergency use of U40
U409 Emergency use of U40.9
U41 Emergency use of U41
U419 Emergency use of U41.9
U42 Emergency use of U42
U429 Emergency use of U42.9
U43 Emergency use of U43
U439 Emergency use of U43.9
U44 Emergency use of U44
U449 Emergency use of U44.9
U45 Emergency use of U45
U459 Emergency use of U45.9
U46 Emergency use of U46
U469 Emergency use of U46.9
U47 Emergency use of U47
U479 Emergency use of U47.9
U48 Emergency use of U48
U489 Emergency use of U48.9
U49 Emergency use of U49
U499 Emergency use of U49.9
U82 Resistance to betalactam antibiotics
U82-U85 Resistance to antimicrobial and antineoplastic drugs
U820 Resistance to penicillin
U821 Resistance to methicillin
U822 Extended spectrum betalactamase (ESBL) resistance
U828 Resistance to other betalactam antibiotics
U829 Resistance to betalactam antibiotics, unspecified
U83 Resistance to other antibiotics
U830 Resistance to vancomycin
U831 Resistance to other vancomycin related antibiotics
U832 Resistance to quinolones
U837 Resistance to multiple antibiotics
U838 Resistance to other single specified antibiotic
U839 Resistance to unspecified antibiotic
U84 Resistance to other antimicrobial drugs
U840 Resistance to antiparasitic drug(s)
U841 Resistance to antifungal drug(s)
U842 Resistance to antiviral drug(s)
U843 Resistance to tuberculostatic drug(s)
U847 Resistance to multiple antimicrobial drugs
U848 Resistance to other specified antimicrobial drug
U849 Resistance to unspecified antimicrobial drugs
U85 Resistance to antineoplastic drugs
XXII Codes for special purposes